BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  TetraLogic Pharmaceuticals Licenses Exclusive Rights to Novel Necrosis Inhibitors From Harvard Medical School

  March 9, 2009

   · 

  2 min read
• Drug Development

  Clinical Development of Solasia’s First Drug Initiated in Japan – Clinical Trials Also Planned for China

  March 9, 2009

   · 

  1 min read
• Deals

  ACM Global Central Laboratory Finalizes Acquisition of Pivotal Laboratories

  March 9, 2009

   · 

  1 min read
• Business

  Genavia Therapeutics Licenses Technology from Origen Therapeutics, Inc. for Cost-Efficient Production of Human Therapeutics in Chicken Eggs

  March 9, 2009

   · 

  1 min read
• Pharm Country

  Millennium Biotechnologies, Inc.’ Largest Senior Secured Creditor Agrees to Subordinate and Restructure $3,400,000 of Senior Secured Debt

  March 9, 2009

   · 

  1 min read
• Drug Development

  CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety

  March 9, 2009

   · 

  2 min read
• Business

  Evotec AG and Roche to Develop EVT 101 for Treatment-Resistant Depression; Deal Valued at More Than $300 Million

  March 9, 2009

   · 

  1 min read
• Business

  Merck & Co., Inc. (JOBS) to Buy Schering-Plough Corporation (JOBS) for $41.1 Billion

  March 9, 2009

   · 

  19 min read